Topical Gel Compositions Of Naproxen

Patent No. EP3917493 (titled "Topical Gel Compositions Of Naproxen") was filed by Bayer Healthcare on Jan 8, 2020. The application was issued on Nov 5, 2025.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANAug 4, 2026POTTER CLARKSON

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP3917493

BAYER HEALTHCARE
Application Number
EP20703127A
Filing Date
Jan 8, 2020
Status
Granted And Under Opposition
Oct 3, 2025
Publication Date
Nov 5, 2025